BCHT(SH:688276) Xin Lang Cai Jing·2025-11-17 01:27Group 1 - On November 14, Baike Bio's stock rose by 1.93%, with a trading volume of 235 million yuan [1] - The financing data shows that on the same day, Baike Bio had a financing purchase amount of 41.97 million yuan and a net financing purchase of 10.47 million yuan [1] - As of November 14, the total balance of margin trading for Baike Bio was 237 million yuan, with the financing balance accounting for 2.40% of the circulating market value, indicating a high level compared to the past year [1] Group 2 - As of September 30, Baike Bio had 10,800 shareholders, an increase of 7.23% from the previous period, while the average circulating shares per person decreased by 6.74% to 38,216 shares [2] - For the period from January to September 2025, Baike Bio reported an operating income of 474 million yuan, a year-on-year decrease of 53.76%, and a net profit attributable to shareholders of -158 million yuan, a decrease of 164.76% [2] - Since its A-share listing, Baike Bio has distributed a total of 235 million yuan in dividends, with 194 million yuan distributed over the past three years [2]